COVID-19 vaccination funding changed on 1 October 2026 when the NIP replaced the previous national program. Older advice that vaccination is free for everyone regardless of Medicare status no longer describes the current NIP rules. Clinical recommendations and funded access still need separate assessment. Bring your vaccination history and relevant health information so a clinician can explain what is recommended now and which access pathway applies.
The current funded groups
Under current NIP rules, adults aged 75 and over can receive two funded doses each year, about six months apart. Adults aged 65 to 74, Aboriginal and Torres Strait Islander adults aged 50 to 74, and adults aged 18 to 64 with severe immunocompromise can receive one funded dose annually. You must hold a Medicare card or be eligible for one.
These are funding categories, not a self-assessment tool for every medical circumstance. If immune status is relevant, bring your medicine list and any specialist advice. Having a chronic condition does not automatically mean severe immunocompromise. Ask the clinician to explain which category has been checked and what further information, if any, is needed. If another provider has given different advice, note when that advice was provided because it may predate the October program change.
Clinical advice can extend beyond funded access
The Handbook recommends two annual doses for adults from 75. Some other age and medical-risk groups may consider an additional annual dose after individual assessment, while other adults may consider an annual dose. Pregnancy has separate guidance. A clinically considered dose is not automatically a funded dose under the NIP.
If you are outside a funded category, ask whether vaccination is appropriate and what access options exist. Do not interpret the absence of funding as a diagnosis that you have no risk. Equally, a private option should not be presented as something everyone must purchase. A useful discussion explains the expected benefit in your circumstances, any important limitations and the practical pathway. You should understand the reason for the recommendation before deciding about an appointment or its cost.
Previous doses still help with timing
Current guidance focuses on maintaining protection against severe disease rather than counting everyone through the original pandemic primary-course sequence. Nevertheless, the date of your last vaccination matters. Bring records from Australia and overseas, and tell the clinician if there are gaps or uncertain dates. Do not book solely because an old reminder says a numbered booster is due.
If you have several certificates, arrange them in date order and keep the details visible. If an earlier dose is missing from AIR, identify the provider that gave it. Ask the clinician to explain the timing of the proposed dose in relation to your actual history. If a future review is suggested, clarify whether it is a definite vaccination date or a check of guidance and circumstances at that time. This keeps an administrative reminder from becoming an unintended medical instruction.
Recent infection and current illness need discussion
Tell the clinician if you recently had COVID-19 or are currently unwell. Do not apply a blanket six-month wait after infection as your own rule. Recovery, previous vaccination and individual risk can affect the timing assessment. If you have symptoms before an appointment, contact the provider before attending.
Bring the approximate dates of illness and any relevant advice from your treating team. You do not need to reconstruct an uncertain infection date as an exact one. Explain what is known and let the clinician assess the uncertainty. If treatment or an upcoming medical procedure is involved, ask who should coordinate the plan. A timing decision should be based on the current clinical situation rather than an older internet rule that may have been written for a different phase of the program.
Confirm the access pathway and costs
Eligible NIPVIP services at this pharmacy have no patient charge. If you do not meet funded criteria, ask about suitability, private access and any prescription or referral requirements. The private service fee is $20 per dose, with medicine costs additional. Confirm the provider’s age scope, available stock and appointment arrangements before travelling.
For a child or someone needing specialist assessment, ask which service is appropriate rather than assume an adult pharmacy appointment is suitable. If you help a relative organise care, bring the relevant records with their consent and ensure their own questions are addressed. If a provider cannot offer the required service, ask for a clear next step. Access planning should leave you knowing who to contact and what information to bring, not merely that one appointment type is unavailable.
Make an informed decision and retain the outcome
Discuss expected benefit, possible reactions, uncommon risks and previous serious vaccine reactions before consenting. Vaccination reduces severe-disease risk but does not guarantee that infection or illness will not occur. Ask how to obtain advice after the appointment and follow any relevant instructions from your treating clinician.
Keep the vaccination record and any follow-up plan together. If the decision is to defer or seek specialist advice, write down the reason and who will resolve the outstanding question. If funding rules or recommendations later change, that record gives the next clinician a reliable starting point. The practical goal is a decision based on current guidance and your circumstances, with a clear explanation of what is recommended, what is funded and what happens next.
Sources & further reading
General information only. This article is educational and is not a substitute for personal medical advice. Your immuniser will confirm eligibility and contraindications on the day.
Ask your pharmacist or GP about suitability, benefits, risks and alternatives before making a treatment decision.